Benefiting from the Human Genome

As one of the leading causes of death in the United States, cancer continues to challenge those working in the field. Despite long-ongoing research, much work remains before cancer is eradicated. Really a large family of diseases, cancer requires diverse methods for treatment and diagnosis that will only come with a better knowledge of the basic biology of the affected systems. Advances in understanding the causes, new techniques for drug discovery, and increased funding of cancer research have

Written byJennifer Fisher Wilson
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Advances in understanding the causes, new techniques for drug discovery, and increased funding of cancer research have invigorated the already strong field. These advances have also opened up a wide range of opportunities for life scientists interested in working in cancer research. "Cancer research is a very strong and growing field, especially because of recent major advances in our understanding of the fundamental causes of cancer, and new opportunities to begin to rationally address these abnormalities," says Ronald B. Herberman, director the of University of Pittsburgh Cancer Institute and associate vice chancellor for research, health sciences, University of Pittsburgh. "There's a growing sense of rapid progress being made."

Genomics and proteomics make it possible to isolate tumor samples with precision and evaluate the global changes in gene expression that occur in tumors. "The ability to recognize molecular signatures associated with different tumors should provide substantial improvement in cancer detection and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies